Cited by 407Nanoparticle-Based Drug DeliveryPolymer Surface Interaction StudiesDendrimers and Hyperbranched Polymers

Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers

Open access
Park, Joonyoung, Brust, Tarsis F., Lee, Hong Jae, Lee, Sang Cheon, Watts, Val J., Yeo, Yoon·2014·ACS Nano

Abstract

The surface of a polymeric nanoparticle (NP) is often functionalized with cell-interactive ligands and/or additional polymeric layers to control NP interaction with cells and proteins. However, such modification is not always straightforward when the surface is not chemically reactive. For this reason, most NP functionalization processes employ reactive linkers or coupling agents or involve prefunctionalization of the polymer, which are complicated and inefficient. Moreover, prefunctionalized polymers can lose the ability to encapsulate and retain a drug if the added ligands change the chemical properties of the polymer. To overcome this challenge, we use dopamine polymerization as a way of functionalizing NP surfaces. This method includes brief incubation of the preformed NPs in a weak alkaline solution of dopamine, followed by secondary incubation with desired ligands. Using this method, we have functionalized poly(lactic-co-glycolic acid) (PLGA) NPs with three representative surface modifiers: a small molecule (folate), a peptide (Arg-Gly-Asp), and a polymer [poly(carboxybetaine methacrylate)]. We confirmed that the modified NPs showed the expected cellular interactions with no cytotoxicity or residual bioactivity of dopamine. The dopamine polymerization method is a simple and versatile surface modification method, applicable to a variety of NP drug carriers irrespective of their chemical reactivity and the types of ligands.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/nn405809c

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both PDA and its in vivo degradation products display negligible cytotoxicity and immunogenicity.

    “Extensive in vitro cellular assays and in vivo animal studies have confirmed that both PDA and its in vivo degradation products display negligible cytotoxicity and immunogenicity.”

    From Polydopamine-Based Biomaterials in Oral Medicine: Applications, Mechanisms, and Translational Challenges (2026) · cites this paper as [9]

    The Results and Discussion section, under “Toxicity and biological activity of pD coating” (page not provided), reports no significant cytotoxicity from pD-coated particles or pD aggregates in the tested cells, and cites in vivo findings of low toxicity. It does not establish negligible cytotoxicity or immunogenicity of pD’s in vivo degradation products; it explicitly says pD biodegradation and long-term toxicology remain to be systematically investigated. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. [1]Hong RL Huang CJ Tseng YL Pang VF Chen ST Liu JJ Chang FH Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial? Clin. Cancer Res 1999 5 3645 3652 10589782
  2. [2]Hatakeyama H Akita H Harashima H A Multifunctional Envelope Type Nano Device (Mend) for Gene Delivery to Tumours Based on the Epr Effect: A Strategy for Overcoming the PEG Dilemma Adv. Drug Deliv. Rev 2011 63 152 160 20840859
  3. [3]Gu F Zhang L Teply BA Mann N Wang A Radovic-Moreno AF Langer R Farokhzad OC From the Cover: Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers Proc. Natl. Acad. Sci. U.S.A 2008 105 2586 2591 18272481 PMC2268180
  4. [4]Sawant RM Hurley JP Salmaso S Kale A Tolcheva E Levchenko TS Torchilin VP "Smart" Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers Bioconjugate Chem 2006 17 943 949 PMC2538444 16848401
  5. [5]Hatakeyama H Akita H Kogure K Oishi M Nagasaki Y Kihira Y Ueno M Kobayashi H Kikuchi H Harashima H Development of a Novel Systemic Gene Delivery System for Cancer Therapy with a Tumor-Specific Cleavable PEG-Lipid Gene Ther 2007 14 68 77 16915290
  6. [6]Hatakeyama H Akita H Ito E Hayashi Y Oishi M Nagasaki Y Danev R Nagayama K Kaji N Kikuchi H Systemic Delivery of siRNA to Tumors Using a Lipid Nanoparticle Containing a Tumor-Specific Cleavable PEG-Lipid Biomaterials 2011 32 4306 4316 21429576
  7. [8]Rao KS Reddy MK Horning JL Labhasetwar V TAT-Conjugated Nanoparticles for the CNS Delivery of Anti-HIV drugs Biomaterials 2008 29 4429 4438 18760470 PMC2570783
  8. [9]Narayanan S Binulal NS Mony U Manzoor K Nair S Menon D Folate Targeted Polymeric 'Green' Nanotherapy for Cancer Nanotechnology 2010 21 285107 20585151
  9. [11]Dhar S Gu FX Langer R Farokhzad OC Lippard SJ Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles Proc. Natl. Acad. Sci. U.S.A 2008 105 17356 17361 18978032 PMC2582270
  10. [12]Mo Y Lim LY Paclitaxel-Loaded PLGA Nanoparticles: Potentiation of Anticancer Activity by Surface Conjugation with Wheat Germ Agglutinin J. Control. Release 2005 108 244 262 16213056
  11. [13]Hrkach J Von Hoff D Ali MM Andrianova E Auer J Campbell T De Witt D Figa M Figueiredo M Horhota A Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Sci. Transl. Med 2012 4 128ra139 22491949
  12. [14]Gullotti E Yeo Y Beyond the Imaging: Limitations of Cellular Uptake Study in the Evaluation of Nanoparticles J. Control. Release 2012 164 170 176 22568932 PMC3447109
  13. [15]Farokhzad OC Cheng J Teply BA Sherifi I Jon S Kantoff PW Richie JP Langer R Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy In Vivo Proc. Natl. Acad. Sci. U.S.A 2006 103 6315 6320 16606824 PMC1458875
  14. [16]Zhang Z Huey Lee S Feng SS Folate-Decorated Poly(Lactide-co-Glycolide)-Vitamin E TPGS Nanoparticles for Targeted Drug Delivery Biomaterials 2007 28 1889 1899 17197019
  15. [17]Tosi G Costantino L Rivasi F Ruozi B Leo E Vergoni AV Tacchi R Bertolini A Vandelli MA Forni F Targeting the Central Nervous System: In Vivo Experiments with Peptide-Derivatized Nanoparticles Loaded with Loperamide and Rhodamine-123 J. Control. Release 2007 122 1 9 17651855
  16. [18]Lee H Dellatore SM Miller WM Messersmith PB Mussel-Inspired Surface Chemistry for Multifunctional Coatings Science 2007 318 426 430 17947576 PMC2601629
  17. [19]Lee H Rho J Messersmith PB Facile Conjugation of Biomolecules onto Surfaces via Mussel Adhesive Protein Inspired Coatings Adv. Mater 2009 21 431 434 19802352 PMC2755254
  18. [20]Lu L Li QL Maitz MF Chen JL Huang N Immobilization of the Direct Thrombin Inhibitor-Bivalirudin on 316l Stainless Steel via Polydopamine and the Resulting Effects on Hemocompatibility In Vitro J. Biomed. Mater. Res. A 2012 100 2421 2430 22566466
  19. [21]Kang K Choi IS Nam Y Biofunctionalization Scheme for Neural Interfaces Using Polydopamine Polymer Biomaterials 2011 32 6374 6380 21652066
  20. [23]Zhu L-P Jiang J-H Zhu B-K Xu Y-Y Immobilization of Bovine Serum Albumin onto Porous Polyethylene Membranes Using Strongly Attached Polydopamine as a Spacer Colloids Surf. B Biointerfaces 2011 86 111 118 21497492
  21. [25]Yang SH Kang SM Lee K-B Chung TD Lee H Choi IS Mussel-Inspired Encapsulation and Functionalization of Individual Yeast Cells J. Am. Chem. Soc 133 2795 2797 21265522
  22. [26]Xu P Gullotti E Tong L Highley CB Errabelli DR Hasan T Cheng J-X Kohane DS Yeo Y Intracellular Drug Delivery by Poly(Lactic-co-Glycolic Acid) Nanoparticles, Revisited Mol. pharmaceutics 2009 6 190 201 PMC2653259 19035785
  23. [27]Amoozgar Z Park J Lin Q Weidle JH Yeo Y Development of Quinic Acid-Conjugated Nanoparticles as a Drug Carrier to Solid Tumors Biomacromolecules 2013 14 2389 2395 23738975 PMC3717395
  24. [28]Amoozgar Z Park J Lin Q Yeo Y Low Molecular-Weight Chitosan as a Ph-Sensitive Stealth Coating for Tumor-Specific Drug Delivery Mol. pharmaceutics 2012 9 1262 1270 PMC3355976 22489704
  25. [29]Lee H Scherer NF Messersmith PB Single-Molecule Mechanics of Mussel Adhesion Proc. Natl. Acad. Sci. U.S.A 2006 103 12999 13003 16920796 PMC1559742
  26. [30]Jiang J-H Zhu L-P Zhu L-J Zhu B-K Xu Y-Y Surface Characteristics of Self-Polymerized Dopamine Coating Deposited on Hydrophobic Polymer Films Langmuir 2011 27 14180 14187 22011109
  27. [33]Hilgenbrink AR Low PS Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics J. Pharm. Sci 2005 94 2135 2146 16136558
  28. [34]Shuhendler AJ Prasad P Leung M Rauth AM Dacosta RS Wu XY A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor αvβ3 Integrin Receptors Reveals Cyclic RGD as a Double-Edged Sword Adv. Healthc. Mater 2012 1 600 608 23184795
  29. [35]Zhang L Xue H Gao C Carr L Wang J Chu B Jiang S Imaging and Cell Targeting Characteristics of Magnetic Nanoparticles Modified by a Functionalizable Zwitterionic Polymer with Adhesive 3,4-Dihydroxyphenyl-L-Alanine Linkages Biomaterials 2010 31 6582 6588 20541254
  30. [36]Li G Cheng G Xue H Chen S Zhang F Jiang S Ultra Low Fouling Zwitterionic Polymers with a Biomimetic Adhesive Group Biomaterials 2008 29 4592 4597 18819708
  31. [37]Gao C Li G Xue H Yang W Zhang F Jiang S Functionalizable and Ultra-Low Fouling Zwitterionic Surfaces via Adhesive Mussel Mimetic Linkages Biomaterials 2010 31 1486 1492 19962753
  32. [38]Zhang Z Chen S Jiang S Dual-Functional Biomimetic Materials: Nonfouling Poly(Carboxybetaine) with Active Functional Groups for Protein Immobilization Biomacromolecules 2006 7 3311 3315 17154457
  33. [40]Liu Y Ai K Lu L Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields Chem. Rev 2014 24517847
  34. [41]Shao Q He Y White AD Jiang S Difference in Hydration between Carboxybetaine and Sulfobetaine J. Phys. Chem. B 2010 114 16625 16631 21086974
  35. [43]Gullotti E Park J Yeo Y Polydopamine-Based Surface Modification for the Development of Peritumorally Activatable Nanoparticles Pharm. Res 2013 30 1956 1967 23609560 PMC3700573
  36. [44]Ku SH Ryu J Hong SK Lee H Park CB General Functionalization Route for Cell Adhesion on Non-Wetting Surfaces Biomaterials 2010 31 2535 2541 20061015
  37. [45]Ku SH Park CB Human Endothelial Cell Growth on Mussel-Inspired Nanofiber Scaffold for Vascular Tissue Engineering Biomaterials 2010 31 9431 9437 20880578
  38. [46]Hong S Kim KY Wook HJ Park SY Lee KD Lee DY Lee H Attenuation of the In Vivo Toxicity of Biomaterials by Polydopamine Surface Modification Nanomedicine 2011 6 793 801 21793672
  39. [47]Zheng Q Lin T Wu H Guo L Ye P Hao Y Guo Q Jiang J Fu F Chen G Mussel-Inspired Polydopamine Coated Mesoporous Silica Nanoparticles as Ph-Sensitive Nanocarriers for Controlled Release Int. J. Pharm 2014 463 22 26 24393764
  40. [48]Liu Y Ai K Liu J Deng M He Y Lu L Dopamine-Melanin Colloidal Nanospheres: An Efficient near-Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy Adv. Mater 2013 25 1353 1359 23280690
  41. [49]Liu X Cao J Li H Li J Jin Q Ren K Ji J Mussel-Inspired Polydopamine: A Biocompatible and Ultrastable Coating for Nanoparticles In Vivo ACS Nano 2013 7 9384 9395 24010584
  42. [50]Danhier F Vroman B Lecouturier N Crokart N Pourcelle V Freichels H Jerome C Marchand-Brynaert J Feron O Preat V Targeting of Tumor Endothelium by RGD-Grafted PLGA-Nanoparticles Loaded with Paclitaxel J. Control. Release 2009 140 166 173 19699245
  43. [51]Tabata Y Ikada Y Effect of the Size and Surface Charge of Polymer Microspheres on Their Phagocytosis by Macrophage Biomaterials 1988 9 356 362 3214660
  44. [52]Müller R Rühl D Lück M Paulke BR Influence of Fluorescent Labelling of Polystyrene Particles on Phagocytic Uptake, Surface Hydrophobicity, and Plasma Protein Adsorption Pharm. Res 1997 14 18 24 9034216

Cited by

Sorted by citations

Authors
Park, J., Brust, T. F., Lee, H. J., Lee, S. C., Watts, V. J., & Yeo, Y.
Affiliations
  • Purdue University West Lafayette (US)
  • Kyung Hee University (KR)
Corresponding author
Yeo, Yoon
Venue
ACS Nano
Published
2014-03-19
Volume
8
Issue
4
Pages
3347-3356
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W2335405043
Cited by
407
References
4
Citations by year
2026: 13 · 2025: 15 · 2024: 24 · 2023: 34 · 2022: 33 · 2021: 33 · 2020: 37 · 2019: 56 · 2018: 59 · 2017: 42 · 2016: 34 · 2015: 23 · 2014: 4
FWCI
13.02
Type
journal article
Language
en
Open access
Locations
  • ACS Nano (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Science Foundation (DMR-1056997)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
polydopamine, surface modification, polymeric nanoparticles, drug carriers, PLGA nanoparticles, dopamine polymerization, folic acid, RGD peptide, poly(carboxybetaine methacrylate), ligand conjugation, nanoparticle-cell interactions, nanoparticle-protein interactions
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Betaine, Biological Transport, Drug Carriers, Folic Acid, Humans, Indoles, KB Cells, Oligopeptides, Particle Size, Polyglycolic Acid, Polymers, Polymethacrylic Acids, Safety, Surface Properties, Lactic Acid, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review